Related Experiment Video
Updated: Apr 27, 2026
Animal Models of Depression - Chronic Despair Model CDM
Published on: September 23, 2021
Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of
Nikita N Burke1, Daniel M Kerr2, Orla Moriarty3
1Physiology, School of Medicine, National University of Ireland Galway, University Road, Galway, Ireland; Pharmacology and Therapeutics, School of Medicine, National University of Ireland Galway, University Road, Galway, Ireland.
Abstract:
There is a paucity of data on the role of microglia and neuroinflammatory processes in the association between chronic pain and depression. The current study examined the effect of the microglial inhibitor minocycline on depressive-like behaviour, spinal nerve ligation (SNL)-induced mechanical and cold allodynia and associated changes in the expression of genes encoding microglial markers (M1 vs. M2 polarisation) and inflammatory mediators in the prefrontal cortex in the olfactory bulbectomised (OB) rat model of depression. Acute minocycline administration did not alter OB-induced depressive-like behaviour but prevented SNL-induced mechanical allodynia in both OB and sham rats. In comparison, chronic minocycline attenuated OB-induced depressive-like behaviour and prevented the development of SNL-induced mechanical allodynia in OB, but not sham, rats. Further analysis revealed that SNL-induced mechanical allodynia in OB rats was attenuated by chronic minocycline at almost all time-points over a 2week testing period, an effect observed only from day 10 post-SNL in sham rats. Chronic administration of minocycline reduced the expression of CD11b, a marker of microglial activation, and the M1 pro-inflammatory cytokine IL-1β, in the prefrontal cortex of sham-SNL animals. In comparison, the expression of the M2 microglia marker (MRC2) and anti-inflammatory cytokine IL-10 was increased, as were IL-1β, IL-6 and SOCS3, in the prefrontal cortex of OB-SNL animals following chronic minocycline. Thus, chronic minocycline attenuates neuropathic pain behaviour and modulates microglial activation and the central expression of inflammatory mediators in a manner dependent on the presence or absence of a depressive-like phenotype.
Insights
Chronic minocycline reduced depressive behavior and neuropathic pain in rats by modulating microglial activation and inflammatory mediators in the prefrontal cortex.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Chronic pain and depression often coexist, with neuroinflammation and microglial activation implicated.
- Limited data exists on the specific roles of microglia and inflammatory processes in this comorbidity.
Purpose of the Study:
- To investigate the effects of minocycline, a microglial inhibitor, on depressive-like behavior and neuropathic pain.
- To analyze changes in microglial polarization markers and inflammatory mediators in the prefrontal cortex.
Main Methods:
- Used olfactory bulbectomised (OB) rats as a model for depression.
- Administered minocycline acutely and chronically.
- Induced neuropathic pain via spinal nerve ligation (SNL).
- Assessed depressive-like behavior, mechanical/cold allodynia, and gene expression of microglial markers (M1/M2) and inflammatory mediators.
Main Results:
- Acute minocycline did not affect depressive behavior but reduced SNL-induced allodynia.
- Chronic minocycline attenuated depressive behavior and SNL-induced allodynia in OB rats.
- Chronic minocycline modulated microglial markers (CD11b, MRC2) and inflammatory mediators (IL-1β, IL-10, IL-6, SOCS3) in the prefrontal cortex, with effects dependent on the depressive phenotype.
Conclusions:
- Chronic minocycline effectively treats neuropathic pain and depressive-like behaviors in rats.
- Minocycline's therapeutic effects involve modulating microglial activation and neuroinflammation in the prefrontal cortex.
- The response to minocycline is influenced by the presence of a depressive-like state.
